NMPA Suspends Two Indian Pharma APIs Over GMP Violations
China’s National Medical Products Administration (NMPA) announced enforcement actions against two India‑based active pharmaceutical ingredient...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity